Philadelphia chromosome (Ph+) or t(9;22)(q34;q11.2) occurs in 3–5% of childhood B-ALL and nearly all patients with chronic myeloid leukemia (CML), which results in BCR-ABL1 fusion gene [24]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.